Clinical Trial Update: Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different dosing intervals of SST-0225 topical ibuprofen cream for delayed onset muscle soreness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed-onset Muscle Soreness

Drugs mentioned

• SST-0225 topical ibuprofen cream (ibuprofen)

Snippet

Sponsor: Strategic Science & Technologies, LLC | Conditions: Delayed Onset Muscle Soreness | Phase 2 | Status: COMPLETED